The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature
Abstract
Pharmacokinetics (PK) of xenobiotics can differ widely between children and adults due to physiological differences and the immaturity of enzyme systems and clearance mechanisms. This makes extrapolation of adult dosimetry estimates to children uncertain, especially at early postnatal ages. While there is very little PK data for environmental toxicants in children, there is a wealth of such data for therapeutic drugs. Using published literature, a Children's PK Database has been compiled which compares PK parameters between children and adults for 45 drugs. This has enabled comparison of child and adult PK function across a number of cytochrome P450 (CYP) pathways, as well as certain Phase II conjugation reactions and renal elimination. These comparisons indicate that premature and full-term neonates tend to have 3 to 9 times longer half-life than adults for the drugs included in the database. This difference disappears by 2-6 months of age. Beyond this age, half-life can be shorter than in adults for specific drugs and pathways. The range of neonate/adult half-life ratios exceeds the 3.16-fold factor commonly ascribed to interindividual PK variability. Thus, this uncertainty factor may not be adequate for certain chemicals in the early postnatal period. The current findings present a PK developmental profile that is relevant to environmental toxicants metabolized and cleared by the pathways represented in the current database. The manner in which this PK information can be applied to the risk assessment of children includes several different approaches: qualitative (e.g., enhanced discussion of uncertainties), semiquantitative (age group-specific adjustment factors), and quantitative (estimation of internal dosimetry in children via physiologically based PK modeling).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Konz, J. J., Lisi, K., Friebele, E., & Dixon, D. (1989) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 2,219
Cognitive Deficit in 7-Year-Old Children with Prenatal Exposure to Methylmercury
Grandjean, P., Weihe, P., White, R. F., Debes, F., Araki, S., Yokoyama, K., Murata, K., SØRENSEN, N., Dahl, R., & JØRGENSEN, P. J. (1997) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(97)00097-4 · Cited by 1,738
Pesticides in the Diets of Infants and Children
(1993) · National Academies Press eBooks · doi:10.17226/2126 · Cited by 859
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Low-Level Lead Exposure, Intelligence and Academic Achievement: A Long-term Follow-up Study
Bellinger, D. C., Stiles, K. M., & Needleman, H. L. (1992) · Pediatrics · doi:10.1542/peds.90.6.855 · Cited by 676
Thurlbeck, W. M. (1982) · Thorax · doi:10.1136/thx.37.8.564 · Cited by 604
Lacroix, D., Sonnier, M., Moncion, A., Cheron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 539
Third national health and nutrition examination survey
Maurer, K. R. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90062-6 · Cited by 522
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E. S., Tyndale, R. F., & Sellers, E. M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36947-2 · Cited by 453
Mechanisms underlying Children's susceptibility to environmental toxicants.
Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., & Ponce, R. A. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s113 · Cited by 344
Wormhoudt, L. W., Commandeur, J. N. M., & Vermeulen, N. P. E. (1999) · Critical Reviews in Toxicology · doi:10.1080/10408449991349186 · Cited by 302
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
Nakajima, M., Yamamoto, T., Nunoya, K., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., & Kuroiwa, Y. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12887-5 · Cited by 284
Vieira, I., Sonnier, M., & Cresteil, T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0476z.x · Cited by 265
Pope, C. N., Chakraborti, T. K., Chapman, M. L., Farrar, J. D., & Arthun, D. (1991) · Toxicology · doi:10.1016/0300-483x(91)90061-5 · Cited by 242
von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., Duan, S. X., Harrel, L. M., Cotreau-Bibbo, M. M., Pritchard, G. A., Wright, C. E., & Shader, R. I. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12284-2 · Cited by 225
Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
Anderson, B. J., McKee, A. D., & Holford, N. H. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00001 · Cited by 210
Besunder, J. B., Reed, M. D., & Blumer, J. L. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814040-00001 · Cited by 206
Clinical Pharmacokinetics in Infants and Children A Reappraisal
Kearns, G. L., & Reed, M. D. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900171-00005 · Cited by 199
Tanaka, E. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00086.x · Cited by 192
The Pharmacological Basis of Therapeutics.
Fahn, S. (1966) · Archives of Neurology · doi:10.1001/archneur.1966.00470100112020 · Cited by 192
Levy, G., Khanna, N. N., Soda, D. M., Tsuzuki, O., & Stern, L. (1975) · Pediatrics · doi:10.1542/peds.55.6.818 · Cited by 187
Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
Yanagihara, Y., Kariya, S., Ohtani, M., Uchino, K., Aoyama, T., Yamamura, Y., & Iga, T. (2001) · PubMed · Cited by 187
Besunder, J. B., Reed, M. D., & Blumer, J. L. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814050-00001 · Cited by 178
Engel, G., Hofmann, U., Heidemann, H., Cosme, J., & Eichelbaum, M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90001-6 · Cited by 176
In vivo age-related changes in hepatic drug-oxidizing capacity in humans
Tanaka (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00164.x · Cited by 174
Onset of xenobiotic metabolism in children: Toxicological implications
Cresteil, T. (1998) · Food Additives & Contaminants · doi:10.1080/02652039809374614 · Cited by 158
Lasker, J. M., Wester, M. R., Aramsombatdee, E., & Raucy, J. L. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0615 · Cited by 150
Midazolam is metabolized by at least three different cytochrome P450 enzymes
Wandel, C., Böcker, R. H., Bohrer, H., BROWNE, A., Rügheimer, E., & MARTIN, E. (1994) · British Journal of Anaesthesia · doi:10.1093/bja/73.5.658 · Cited by 149
Yamazaki, H., Nakano, M., Imai, Y., Ueng, Y., Guengerich, F. P., & Shimada, T. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0022 · Cited by 143
Developmental Expression of Cytochrome P450 Enzymes in Human Liver
Hakkola, J., Tanaka, E., & Pelkonen, O. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01427.x · Cited by 128
Ratanasavanh, D., Beaune, P. H., Morel, F., Flinois, J.-P., Guengerich, F. P., & Guillouzo, A. (1991) · Hepatology · doi:10.1002/hep.1840130622 · Cited by 124
Pharmacokinetics, Metabolism, and Toxicology of Dichloroacetate
Stacpoole, P. W., Henderson, G. N., Yan, Z., Cornett, R., & James, M. O. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996323 · Cited by 123
Mechanisms Underlying Children's Susceptibility to Environmental Toxicants
Faustman, E. M., Silbernagel, S. M., Fenske, R. A., et al. (2000) · Environmental Health Perspectives · doi:10.2307/3454629 · Cited by 121
Clinical Pharmacology of the Perinatal Period and Early Infancy
Morselli, P. L. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900171-00004 · Cited by 118
Nicotine metabolism and elimination kinetics in newborns
Dempsey, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106129 · Cited by 112
Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
Blanco, J. G., Harrison, P. L., Evans, W. E., & Relling, M. V. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15052-0 · Cited by 102
Uncertainty factors for chemical risk assessment
Dorne, J. L. C. M., Walton, K., & RENWICK, A. G. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00005-9 · Cited by 98
An Analysis of the Need for an Additional Uncertainty Factor for Infants and Children
RENWICK, A. G., Dorne, J. L. C. M., & Walton, K. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1394 · Cited by 98
Kawashiro, T., Yamashita, K., Zhao, X., Koyama, E., Tani, M., Chiba, K., & Ishizaki, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37724-9 · Cited by 97
Clinical Pharmacokinetics of Sedatives in Neonates
Jacqz-Aigrain, É., & Burtin, P. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631060-00003 · Cited by 94
Toxicokinetics in infants and children in relation to the ADI and TDI
Renwick, A. G. C. (1998) · Food Additives & Contaminants · doi:10.1080/02652039809374612 · Cited by 91
Ekström, G., & Gunnarsson, U. B. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07489-6 · Cited by 89
Guitton, J., Buronfosse, T., Desage, M., Lepape, A., Brazier, J. L., & Beaune, P. H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00893-3 · Cited by 86
CYP2C19 Participates in Tolbutamide Hydroxylation by Human Liver Microsomes
Wester, M. R., Lasker, J. M., Johnson, E. F., & Raucy, J. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15373-1 · Cited by 71
Pelekis, M., Gephart, L. A., & Lerman, S. (2001) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1436 · Cited by 71
Oxidative Metabolism of Bupivacaine into Pipecolylxylidine in Humans Is Mainly Catalyzed by CYP3A
Gantenbein, M., Attolini, L., Bruguerolle, B., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15053-2 · Cited by 69
Ohmori, S., Nakasa, H., Asanome, K., Kurose, Y., Ishii, I., Hosokawa, M., & Kitada, M. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00156-6 · Cited by 68
Caffeine Acetylator Phenotyping during Maturation in Infants
Pariente‐Khayat, A., Pons, G., Rey, E., Richard, M., d’Athis, P., Moran, C., Badoual, J., & Olivé, G. (1991) · Pediatric Research · doi:10.1203/00006450-199105010-00015 · Cited by 58
Cytochrome P-450 expression in sudden infant death syndrome
Tréluyer, J., Chéron, G., Sonnier, M., & Cresteil, T. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00253-5 · Cited by 57
Hadama, A., Ieiri, I., Morita, T., et al. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200104000-00004 · Cited by 27
Hamaoka, N., Oda, Y., Hase, I., & Asada, A. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/86.4.540 · Cited by 27
Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.
Kobayashi, K., Kogo, M., Tani, M., et al. (2001) · PubMed · Cited by 23
Cited by
Children's health and the environment: public health issues and challenges for risk assessment.
Landrigan, P. J., Kimmel, C. A., Correa, A., & Eskenazi, B. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6115 · Cited by 445
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
Detailed review of transgenic rodent mutation assays
Lambert, I. B., Singer, T. M., Boucher, S. E., & Douglas, G. R. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2005.04.002 · Cited by 360
Developmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Paediatric pharmacokinetics: key considerations
Batchelor, H. K., & Marriott, J. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12267 · Cited by 355
Metadata
- Authors
- Ginsberg, G.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-01
- Volume
- 66
- Issue
- 2
- Pages
- 185-200
- ISSN
- 1096-0929 (ISSN-L)
- OpenAlex
- W2123828545
- Cited by
- 332
- References
- 52
- FWCI
- 15.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.